Diagnostics & Diseases Market Research Reports & Industry Analysis

... from VPGMarketResearch provides insightful analysis of Sherwin-Williams capabilities, goals and strategies in the global paint and ... Customer relations. Internally developed and acquired technologies, processes, and related capabilities. Proprietary technologies and patent litigations. Contains 16 pages ...

... from VPGMarketResearch provides insightful analysis of Valspar's capabilities, goals and strategies in the global paint and coatings ... . Customer relations. Internally developed and acquired technologies, processes, and related capabilities. Proprietary technologies and patent litigations. Contains 12 pages ...

... of leading blood banking automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging suppliers of blood banking products, including ...

... strategies of the worlds leading ultrasound companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. To assist potential market entrants in evaluating prospective acquisition ...

... by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. Estimated universe of laboratories performing cancer diagnostic testing by country. Cancer ...

... : - Blood Centers Plasma Fractionation Facilities Hospitals Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review of automated and semi-automated molecular and immunohematology analyzers.Technology ...

... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...

... 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused ... also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing ...

... coagulation laboratory tests, as well as extensive listings of companies developing or marketing new coagulation technologies and products. The report also includes strategic assessments of current and emerging suppliers of coagulation ...

... from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales ... . The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key ...

... a comprehensive analysis of the Italian hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic hospital laboratory practice, as well ... forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in Italian hospitals, including controls, calibrators and ...

... global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report provides test volume ... trends in the U.S., Europe, Japan; provides test volume and sales forecasts by country, market segment and individual test; compares features of leading analyzers; and profiles ...

... provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading ... Ab, TPO Ab and TSH.During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused ...

... provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading ... and market segment for the following assays: AmphetaminesAntidepressantsBarbituratesBenzodiazepinesCannabinoids/MarijuanaCocaineLSDMethadoneMethaqualoneOpiatesPhencyclidine (PCP)Propoxphene During the next decade, the abused drug testing market will undergo ...

... -page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene.During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

... 71-page report reviews current instrumentation technologies, and compares features of leading automated and semiautomated analyzers ... presents strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative ...

... ambulatory care centers, including controls, calibrators and consumables.RationaleThe clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Care CentersCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... and consumable suppliers during the next five years. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... Heparin testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Heparin testing market ... as well as 5-year test volume forecasts by country and market segment. The report examines market applications of chromogenic substrates, ...

... Fibrinogen testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the Fibrinogen testing market ... well as 5-year test volume forecasts by country and market segment. The report examines market applications of chromogenic ...

... of the AT III testing closer to the patient, creating additional opportunities and challenges for suppliers. This report presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume ...

... malignancy assays and the rapid market expansion worldwide.This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany ... test volume and sales forecasts by country and market segment.The report also examines market applications of DNA probes, biochips/microarrays, monoclonal ...

... technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the ... report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan ...

... of clinical chemistry immunodiagnostic testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Overview of the clinical significance ... -volume/POC clinical chemistry and immunodiagnostic systems. Current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics ...

... overview of the laboratory and POC coagulation testing markets, including estimates of facilities performing coagulation tests, test volume and sales forecasts for coagulation reagents and ... test volume estimates for 38 coagulation assays.The report also presents strategic profiles of current and emerging suppliers of coagulation products in terms of their ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Private LaboratoriesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Group PracticesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests.- Review of current instrumentation technologies, and feature ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... ambulatory care centers, including controls, calibrators and consumables.RationaleThe clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... Laboratories Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... ambulatory care centers, including controls, calibrators and consumables.RationaleThe clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence ... /Group PracticesCurrent and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature ...

... coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation ... characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... and consumable suppliers during the next five years.Coagulation TestsActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...

... care centers, including controls, calibrators and consumables. Rationale The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new ... Antidepressants. Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and feature comparison ...

... Analysis Sales and market share estimates for leading suppliers of clinical chemistry and immunodiagnostic products by country and individual product. Geographic Regions ... Centers Current and Emerging Products Analysis of current and emerging clinical chemistry and immunodiagnostic tests. Review of current instrumentation technologies, and a feature ...

... assessment of Ceva's technological know-how, marketing tactics and strategic directions in the global animal health market.Technological Know-How- Internally developed and acquired animal health technologies, processes and related capabilities.- Proprietary technologies and ...

... assessment of Merck's technological know-how, marketing tactics and strategic directions in the global animal health market.Technological Know-How- Internally developed and acquired animal health technologies, processes and related capabilities.- Proprietary technologies and ...

... unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Abbott and its main competitors, as well as a profile of the companys diagnostics business ...

... the next ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin ... over 40 blood banking tests, including NAT, by market segment: - Blood Centers- Plasma Fractionation Facilities- Hospitals- Commercial/Private Laboratories- Military Blood BanksCurrent and ...

... for further automating molecular diagnostic methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the ... probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio ...

This report reviews operating characteristics and features of 50 high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems. Contains 33 pages

This report reviews major analyzers used for microbiology testing, including their operating characteristics, features and selling prices. Contains 20 pages

The report identifies the major opportunities for hematology and flow cytometry instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers. Contains 23 pages

This 42-page report provides detailed analyses of current and emerging hematology and flow cytometry technologies, and their potential market applications ...

... assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for hemostasis testing.The report also includes strategic assessments of current and emerging suppliers of hemostasis products, including marketing tactics, technological know-how ...